These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15968980)

  • 1. [Induction of protective immunity in rhesus monkey by inoculation with recombinant fusion protein of cholera toxin B subunit-multivalent epitopes of Plasmodium falciparum].
    Li P; Zhong H; Shi CH; Li JZ; Zhang YH; Li CF; Shi YL; Ma QJ; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):516-9. PubMed ID: 15968980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of protective immune response in mice and rhesus monkeys by immunization with fusion protein of cholera toxin B subunit and multiples of Plasmodium falciparum].
    Cao C; Li P; Shi CH; Zhong H; Li JZ; Shi YL; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2000 May; 16(3):333-6. PubMed ID: 11059275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of protective immune responses in rhesus monkey by immunization with recombinant plasmids of polyvalent epitopes of Plasmodium falciparum using cholera toxin B as adjuvant].
    Zhong H; Cao C; Li P; Zhang YH; Shi YL; Ma QJ
    Yi Chuan Xue Bao; 2000; 27(11):966-71. PubMed ID: 11209690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of malaria DNA vaccines in mice and monkeys].
    Zhong H; Cao C; Li P; Li JZ; Ma QJ
    Yi Chuan Xue Bao; 2000; 27(2):95-100. PubMed ID: 10887674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B.
    Ayalew S; Step DL; Montelongo M; Confer AW
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):295-302. PubMed ID: 19581005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination trials and immune response against Plasmodium falciparum in Saimiri monkeys].
    Perraut R; Gerraud O
    Med Trop (Mars); 1998; 58(1):76-84. PubMed ID: 9718561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.
    Hisaeda H; Saul A; Reece JJ; Kennedy MC; Long CA; Miller LH; Stowers AW
    J Infect Dis; 2002 Mar; 185(5):657-64. PubMed ID: 11865423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
    Dutta S; Kaushal DC; Ware LA; Puri SK; Kaushal NA; Narula A; Upadhyaya DS; Lanar DE
    Infect Immun; 2005 Sep; 73(9):5936-44. PubMed ID: 16113314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey.
    Wijayalath WA; Cheesman S; Rajakaruna J; Handunnetti SM; Carter R; Pathirana PP
    Parasite Immunol; 2008; 30(11-12):630-6. PubMed ID: 19067844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary study of a recombinant polyvalent vaccine of Plasmodium falciparum and its immunological activity].
    Li Q; Li Y; Xie Y
    Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):325-8, 381. PubMed ID: 7553140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli.
    Li M; Bi H; Dong W; Xu W; Li Q; Li Y
    Chin Med J (Engl); 1999 Aug; 112(8):691-7. PubMed ID: 11601273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
    Epstein JE; Charoenvit Y; Kester KE; Wang R; Newcomer R; Fitzpatrick S; Richie TL; Tornieporth N; Heppner DG; Ockenhouse C; Majam V; Holland C; Abot E; Ganeshan H; Berzins M; Jones T; Freydberg CN; Ng J; Norman J; Carucci DJ; Cohen J; Hoffman SL
    Vaccine; 2004 Apr; 22(13-14):1592-603. PubMed ID: 15068840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
    Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J
    J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
    Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K
    Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.